Table 1.
Thromboprophylactic | Group A | Group B |
---|---|---|
regimen | Bemiparin 3500 IU/5 days | Bemiparin 3500 IU/10 days |
Number of cases (n) | 311 | 335 |
Mean age ± SD | 31.37 ± 5.24 | 31.06 ± 5.62 |
Age ≥35 years (n) (%) | 89 (28.61%) | 98 (29.25%) |
Parity (n) (%) | ||
0 | 149 (47.9%) | 174 (51.9%) |
1 | 90 (28.9%) | 101 (30.1%) |
2 | 46 (14.8%) | 41 (12.2%) |
3 | 13 (4.2%) | 13 (3.9%) |
≥4 | 13 (4.2%) | 6 (1.8%) |
BMI (n) (%) | ||
BMI > 30 | 142 (45.8%) | 116 (34.62%) |
BMI > 35 | 36 (11.6%) | 22 (6.56%) |
Smoking (n) (%) | 51 (16.5%) | 40 (11.9%) |
>10 cigs./day | 16 (16%) | 9 (2.25%) |
Drug consumption (n) (%) | 1 (0.3%) | 1 (0.3%) |
Multiple pregnancy (n) (%) | 13 (4.2%) | 19 (5.6%) |
Hypertension (n) (%) | ||
Chronic hypertension | 6 (1.9%) | 0 |
PIH in previous pregnancy | 4 (1.3%) | 6 (1.8%) |
PIH in current pregnancy | 34 (10.9%) | 35 (10.4%) |
Diabetes (n) (%) | 15 (4.82%) | 26 (1.8%) |
Type I | 3 (1%) | 2 (0.6%) |
Gestational diabetes | 8 (2.6%) | 18 (5.4%) |
Carbohydrate intolerance | 4 (1.3%) | 6 (1.8%) |
Previous heart disease (n) (%) | 0 | 1 (0.3%) |
Immobility (n) (%) | 0 | 1 (0.3%) |
BMI: body mass index, PIH: pregnancy-induced hypertension.